| Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial Y Ray, SR Paul, P Bandopadhyay, R D’Rozario, J Sarif, A Lahiri, ... MedRxiv, 2020.11. 25.20237883, 2020 | 72 | 2020 |
| Nature and dimensions of systemic hyperinflammation and its attenuation by convalescent plasma in severe COVID-19 P Bandopadhyay, R D’Rozario, A Lahiri, J Sarif, Y Ray, SR Paul, R Roy, ... The Journal of infectious diseases 224 (4), 565-574, 2021 | 59 | 2021 |
| Structural specificities of cell surface β-glucan polysaccharides determine commensal yeast mediated immuno-modulatory activities C Lee, R Verma, S Byun, EJ Jeun, GC Kim, S Lee, HJ Kang, CJ Kim, ... Nature communications 12 (1), 3611, 2021 | 49 | 2021 |
| A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19 Y Ray, SR Paul, P Bandopadhyay, R D’Rozario, J Sarif, D Raychaudhuri, ... Nature Communications 13 (1), 383, 2022 | 36 | 2022 |
| Proteasome dysfunction under compromised redox metabolism dictates liver injury in NASH through ASK1/PPARγ binodal complementary modules D Das, A Paul, A Lahiri, M Adak, SK Maity, A Sarkar, S Paul, ... Redox biology 45, 102043, 2021 | 19 | 2021 |
| Butyrate limits inflammatory macrophage niche in NASH A Sarkar, P Mitra, A Lahiri, T Das, J Sarkar, S Paul, P Chakrabarti Cell Death & Disease 14 (5), 332, 2023 | 18 | 2023 |
| Human FKBP5 negatively regulates transcription through inhibition of P-TEFb complex formation DP Mall, S Basu, K Ghosh, N Kumari, A Lahiri, S Paul, D Biswas Molecular and Cellular Biology, 2022 | 12 | 2022 |
| Nature and dimensions of the cytokine storm and its attenuation by convalescent plasma in severe COVID-19 P Bandopadhyay, R D’Rozario, A Lahiri, J Sarif, Y Ray, SR Paul, R Roy, ... medRxiv, 2020.09. 21.20199109, 2020 | 11 | 2020 |
| Emergence of multiple variants of SARS-CoV-2 with signature structural changes D Bhowmik, S Pal, A Lahiri, A Talukdar, S Paul BioRxiv, 2020.04. 26.062471, 2020 | 10 | 2020 |
| A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19. Nat Commun. 2022; 13: 383 Y Ray, SR Paul, P Bandopadhyay, R D’Rozario, J Sarif, D Raychaudhuri, ... | 5 | |
| Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19 D Talukdar, P Bandopadhyay, Y Ray, SR Paul, J Sarif, R D’Rozario, ... Gut Pathogens 15 (1), 22, 2023 | 4 | 2023 |
| Interplay of Various Evolutionary Modes in Genome Diversification and Adaptive Evolution of the Family Sulfolobaceae R Banerjee, NM Chaudhari, A Lahiri, A Gautam, D Bhowmik, C Dutta, ... Frontiers in Microbiology 12, 639995, 2021 | 4 | 2021 |
| MACI: A machine learning-based approach to identify drug classes of antibiotic resistance genes from metagenomic data RR Chowdhury, J Dhar, SM Robinson, A Lahiri, K Basak, S Paul, ... Computers in Biology and Medicine 167, 107629, 2023 | 1 | 2023 |
| Microbiome Metabolome Integration Platform (MMIP): a web-based platform for microbiome and metabolome data integration and feature identification A Gautam, D Bhowmik, S Basu, W Zeng, A Lahiri, DH Huson, S Paul Briefings in Bioinformatics 24 (6), bbad325, 2023 | 1 | 2023 |
| Integrating Multi-Omics Data to Construct Reliable Interconnected Models of Signaling, Gene Regulatory, and Metabolic Pathways K Kumar, D Bhowmik, S Mandloi, A Gautam, A Lahiri, N Biswas, S Paul, ... Computational Modeling of Signaling Networks, 139-151, 2023 | 1 | 2023 |
| Exploring the resistome and virulome in major sequence types of Acinetobacter baumannii genomes: Correlations with genome divergence and sequence types R Banerjee, SM Robinson, A Lahiri, P Verma, AK Banerjee, S Basak, ... Infection, Genetics and Evolution 119, 105579, 2024 | | 2024 |
| MACI: A machine learning-based approach to identify drug classes of antibiotic resistance genes from metagenomic data J Dhar, SM Robinson, A Lahiri, S Paul, K Basak, R Banerjee | | 2023 |
| Emergence of multiple variants of SARS-CoV-2 with signature structural changes (preprint) D Bhowmik, S Pal, A Lahiri, A Talukdar, S Paul | | 2020 |
| Type I interferon driven gut dysbiosis and insulin resistance P Bandopadhyay, SB Anand, A Lahiri, AR Ghosh, A Gautam, BP Sinha, ... EUROPEAN JOURNAL OF IMMUNOLOGY 49, 1336-1336, 2019 | | 2019 |
